What is the share price of Ishita Drugs and Industries Ltd (ISHITADR) today?
The share price of ISHITADR as on 2nd March 2026 is ₹68.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Ishita Drugs and Industries Ltd (ISHITADR) share?
The past returns of Ishita Drugs and Industries Ltd (ISHITADR) share are- Past 1 week: -4.19%
- Past 1 month: -6.66%
- Past 3 months: -7.87%
- Past 6 months: -9.13%
- Past 1 year: -13.61%
- Past 3 years: 31.95%
- Past 5 years: 143.39%
What are the peers or stocks similar to Ishita Drugs and Industries Ltd (ISHITADR)?
The peers or stocks similar to Ishita Drugs and Industries Ltd (ISHITADR) include:What is the market cap of Ishita Drugs and Industries Ltd (ISHITADR) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ishita Drugs and Industries Ltd (ISHITADR) is ₹20.38 Cr as of 2nd March 2026.What is the 52 week high and low of Ishita Drugs and Industries Ltd (ISHITADR) share?
The 52-week high of Ishita Drugs and Industries Ltd (ISHITADR) is ₹90.85 and the 52-week low is ₹66.What is the PE and PB ratio of Ishita Drugs and Industries Ltd (ISHITADR) stock?
The P/E (price-to-earnings) ratio of Ishita Drugs and Industries Ltd (ISHITADR) is 23.42. The P/B (price-to-book) ratio is 1.89.Which sector does Ishita Drugs and Industries Ltd (ISHITADR) belong to?
Ishita Drugs and Industries Ltd (ISHITADR) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Ishita Drugs and Industries Ltd (ISHITADR) shares?
You can directly buy Ishita Drugs and Industries Ltd (ISHITADR) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Ishita Drugs and Industries Ltd
ISHITADR Share Price
BSE₹68.153.97% (-2.82)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ISHITADR Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ISHITADR Performance & Key Metrics
ISHITADR Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.16 | 1.89 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.67 | 5.79 | 0.58% |
ISHITADR Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ISHITADR Company Profile
Ishita Drugs And Industries is engaged in the manufacturing of various active pharma ingredients, drug intermediates, excipients and fine chemicals.
SUNPHARMA
PE Ratio
38.47
38.47
1Y Return
10.56%
10.56%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
77.37
77.37
1Y Return
47.65%
47.65%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
20.71
20.71
1Y Return
3.97%
3.97%
Buy Reco %
54.84
54.84
DRREDDY
PE Ratio
19.06
19.06
1Y Return
15.61%
15.61%
Buy Reco %
48.39
48.39
LUPIN
PE Ratio
32.19
32.19
1Y Return
18.34%
18.34%
Buy Reco %
72.22
72.22
ISHITADR Forecast
ISHITADR Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
ISHITADR
ISHITADR
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ISHITADR Income Statement
ISHITADR Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.49 | 3.22 | 4.60 | 3.09 | 3.32 | 4.20 | 4.72 | 5.49 | 3.14 | 3.23 | ||||||||||
Operating & Other expenses | 4.18 | 2.98 | 4.20 | 2.85 | 3.04 | 3.83 | 4.27 | 5.05 | 2.88 | 3.00 | ||||||||||
EBITDA | 0.31 | 0.24 | 0.40 | 0.24 | 0.28 | 0.37 | 0.45 | 0.44 | 0.26 | 0.23 | ||||||||||
| Depreciation/Amortization | 0.03 | 0.03 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | ||||||||||
| PBIT | 0.28 | 0.21 | 0.39 | 0.21 | 0.25 | 0.34 | 0.42 | 0.41 | 0.23 | 0.20 | ||||||||||
| Interest & Other Items | 0.01 | 0.04 | 0.02 | 0.01 | 0.00 | 0.02 | 0.04 | 0.02 | 0.00 | 0.02 | ||||||||||
| PBT | 0.27 | 0.17 | 0.37 | 0.20 | 0.25 | 0.32 | 0.38 | 0.39 | 0.23 | 0.18 | ||||||||||
| Taxes & Other Items | 0.07 | 0.04 | 0.09 | 0.05 | 0.06 | 0.08 | 0.09 | 0.09 | 0.08 | 0.04 | ||||||||||
| Net Income | 0.20 | 0.13 | 0.28 | 0.15 | 0.19 | 0.24 | 0.29 | 0.30 | 0.15 | 0.14 | ||||||||||
| EPS | 0.70 | 0.40 | 0.94 | 0.49 | 0.65 | 0.80 | 0.96 | 1.01 | 0.48 | 0.52 |
ISHITADR Company Updates
ISHITADR Stock Peers
ISHITADR Past Performance & Peer Comparison
ISHITADR Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Ishita Drugs and Industries Ltd | 23.42 | 1.89 | — |
| Sun Pharmaceutical Industries Ltd | 38.47 | 5.80 | 0.91% |
| Torrent Pharmaceuticals Ltd | 77.37 | 19.48 | 0.73% |
| Cipla Ltd | 20.71 | 3.49 | 1.18% |
ISHITADR Stock Price Comparison
Compare ISHITADR with any stock or ETFCompare ISHITADR with any stock or ETF
ISHITADR
ISHITADR Holdings
ISHITADR Shareholdings
ISHITADR Promoter Holdings Trend
ISHITADR Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ISHITADR Institutional Holdings Trend
ISHITADR Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ISHITADR Shareholding Pattern
ISHITADR Shareholding Pattern
ISHITADR Shareholding History
ISHITADR Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing ISHITADR stock
smallcases containing ISHITADR stock
Looks like this stock is not in any smallcase yet.
ISHITADR Events
ISHITADR Events
ISHITADR Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ISHITADR has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ISHITADR Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ISHITADR has not given any dividends in last 5 years
ISHITADR Dividends
ISHITADR Dividends
Hmm, looks like data is unavailable here. Please come back after some timeISHITADR Stock News & Opinions
ISHITADR Stock News & Opinions
Articles & Videos
Earnings
Ishita Drugs & Industries standalone net profit declines 33.33% in the December 2025 quarter
Net profit of Ishita Drugs & Industries declined 33.33% to Rs 0.16 crore in the quarter ended December 2025 as against Rs 0.24 crore during the previous quarter ended December 2024. Sales declined 23.97% to Rs 3.14 crore in the quarter ended December 2025 as against Rs 4.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales3.144.13 -24 OPM %4.787.26 - PBDT0.230.35 -34 PBT0.200.32 -38 NP0.160.24 -33 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Ishita Drugs & Industries announces board meeting date
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit declines 26.32% in the September 2025 quarter
Net profit of Ishita Drugs & Industries declined 26.32% to Rs 0.14 crore in the quarter ended September 2025 as against Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 6.12% to Rs 3.07 crore in the quarter ended September 2025 as against Rs 3.27 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales3.073.27 -6 OPM %5.867.03 - PBDT0.250.28 -11 PBT0.220.25 -12 NP0.140.19 -26 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to declare Quarterly Results
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to hold AGM
Ishita Drugs & Industries announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit rises 100.00% in the June 2025 quarter
Net profit of Ishita Drugs & Industries rose 100.00% to Rs 0.30 crore in the quarter ended June 2025 as against Rs 0.15 crore during the previous quarter ended June 2024. Sales rose 78.22% to Rs 5.40 crore in the quarter ended June 2025 as against Rs 3.03 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales5.403.03 78 OPM %6.485.94 - PBDT0.420.23 83 PBT0.390.20 95 NP0.300.15 100 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to convene board meeting
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to hold board meeting
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 13 June 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Ishita Drugs & Industries standalone net profit rises 3.57% in the March 2025 quarter
Net profit of Ishita Drugs & Industries rose 3.57% to Rs 0.29 crore in the quarter ended March 2025 as against Rs 0.28 crore during the previous quarter ended March 2024. Sales rose 1.33% to Rs 4.56 crore in the quarter ended March 2025 as against Rs 4.50 crore during the previous quarter ended March 2024. For the full year,net profit rose 16.00% to Rs 0.87 crore in the year ended March 2025 as against Rs 0.75 crore during the previous year ended March 2024. Sales declined 1.25% to Rs 15.00 crore in the year ended March 2025 as against Rs 15.19 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales4.564.50 1 15.0015.19 -1 OPM %6.366.67 -6.675.99 - PBDT0.410.38 8 1.271.10 15 PBT0.380.37 3 1.160.99 17 NP0.290.28 4 0.870.75 16 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Ishita Drugs & Industries to table results
Ishita Drugs & Industries will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 0.46%, vs industry avg of 9.88%
Over the last 5 years, market share decreased from 0.01% to 0%
Over the last 5 years, net income has grown at a yearly rate of 10.01%, vs industry avg of 19.69%